Danimer Scientific (DNMR)
(Delayed Data from NYSE)
$0.80 USD
+0.02 (2.18%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $0.78 -0.02 (-2.33%) 7:54 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Income Statements
Fiscal Year end for Danimer Scientific, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 47 | 53 | 59 | 47 | 32 |
Cost Of Goods | 74 | 64 | 58 | 36 | 21 |
Gross Profit | -27 | -10 | 1 | 11 | 11 |
Selling & Adminstrative & Depr. & Amort Expenses | 99 | 177 | 100 | 27 | 29 |
Income After Depreciation & Amortization | -126 | -187 | -99 | -16 | -18 |
Non-Operating Income | 0 | 9 | 27 | 6 | 6 |
Interest Expense | 30 | 2 | 1 | 2 | 3 |
Pretax Income | -155 | -181 | -73 | -13 | -15 |
Income Taxes | 0 | -1 | -13 | 0 | 4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -155 | -180 | -60 | -13 | -20 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -155 | -180 | -60 | -13 | -20 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -88 | -165 | -88 | -9 | -13 |
Depreciation & Amortization (Cash Flow) | 38 | 22 | 11 | 7 | 6 |
Income After Depreciation & Amortization | -126 | -187 | -99 | -16 | -18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 102.00 | 101.10 | 93.08 | 29.57 | NA |
Diluted EPS Before Non-Recurring Items | -1.52 | -1.14 | -0.62 | -0.43 | NA |
Diluted Net EPS (GAAP) | -1.52 | -1.78 | -0.65 | -0.43 | NA |
Fiscal Year end for Danimer Scientific, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 10.95 | 10.95 | 12.87 | 11.93 |
Cost Of Goods | NA | 17.32 | 18.69 | 19.43 | 18.21 |
Gross Profit | NA | -6.37 | -7.74 | -6.57 | -6.28 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 24.67 | 23.50 | 24.55 | 25.95 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -31.04 | -31.24 | -31.12 | -32.23 |
Non-Operating Income | NA | 0.11 | 0.13 | 0.98 | -1.12 |
Interest Expense | NA | 8.51 | 8.58 | 9.16 | 3.39 |
Pretax Income | NA | -39.43 | -39.69 | -39.30 | -36.73 |
Income Taxes | NA | 0.00 | 0.47 | -0.06 | -0.09 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -39.43 | -40.16 | -39.24 | -36.64 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -39.43 | -40.16 | -39.24 | -36.64 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 102.15 | 102.03 | 101.94 | 101.90 |
Diluted EPS Before Non-Recurring Items | NA | -0.39 | -0.39 | -0.38 | -0.36 |
Diluted Net EPS (GAAP) | NA | -0.39 | -0.39 | -0.38 | -0.36 |